• Publications
  • Influence
Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis.
BACKGROUND Disorders of mineral metabolism, including secondary hyperparathyroidism, are thought to contribute to extraskeletal (including vascular) calcification among patients with chronic kidneyExpand
  • 668
  • 36
  • PDF
Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO).
Cardiovascular morbidity and mortality in patients with chronic kidney disease (CKD) is high, and the presence of CKD worsens outcomes of cardiovascular disease (CVD). CKD is associated with specificExpand
  • 621
  • 26
  • PDF
Acute Myocardial Infarction and Renal Dysfunction: A High-Risk Combination
Context Advanced renal failure worsens survival after myocardial infarction (MI). The effect of milder renal insufficiency on prognosis is unknown. Contribution Among 3106 patients with MI, those whoExpand
  • 555
  • 25
Poor long-term survival after acute myocardial infarction among patients on long-term dialysis.
BACKGROUND Cardiovascular disease is common in patients on long-term dialysis, and it accounts for 44 percent of overall mortality in this group. We undertook a study to assess long-term survivalExpand
  • 854
  • 24
  • PDF
US Renal Data System 2010 Annual Data Report.
Allan J. Collins, MD, Robert N. Foley, MB, Charles Herzog, MD, Blanche Chavers, MD, David Gilbertson, PhD, Areef Ishani, MD, MS, Bertram Kasiske, MD, Jiannong Liu, PhD, Lih-Wen Mau, PhD, MarshallExpand
  • 334
  • 23
US Renal Data System 2012 Annual Data Report.
  • 355
  • 22
Excerpts from the US Renal Data System 2009 Annual Data Report.
This 21st US Renal Data System Annual Data Report covers data through 2007, and again includes a section on chronic kidney disease (CKD) in the United States. Using NHANES and employer group healthExpand
  • 336
  • 21
Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters.
The KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of CKD-MBD represents a selective update of the prior CKD-MBD Guideline published in 2009.Expand
  • 371
  • 21
Chronic kidney disease and cardiovascular disease in the Medicare population.
BACKGROUND The extent of diabetes, chronic kidney disease (CKD), and cardiovascular disease (CVD) in the Medicare population is relatively unknown. Also unknown is the effect of these diseases onExpand
  • 304
  • 19
Predictive Value of Cardiac Troponin I and T for Subsequent Death in End-Stage Renal Disease
Background—This study determined the prevalence of increased cardiac troponin I (cTnI) and T (cTnT) in end-stage renal disease (ESRD) patients and whether an increased troponin was predictive ofExpand
  • 544
  • 18